MEGLUMINE ANTIMONIATE, pentaval. antimony 81 mg/ml, 5ml, amp


Valid Article

The product is supplied (and stored) sterile, it must remain sterile until its use. Sterile = state of being free from all living microorganisms.
6.5.2 - Antileishmaniasis medicines
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
Anatomical Therapeutic Chemical Classification according to WHOCC
The order of this product needs to be justified and is only acceptable under certain conditions.
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
OC subscriptions: included in supply or field order tools (e.g. UniField)
SC subscriptions: included in supply or field tools
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)

This combination does not exist.

Add article to list


Add Kit To Wishlist


MEGLUMINE antimoniate

Therapeutic Action


Cutaneous and mucocutaneous leishmaniasis

Some restricted information has been hidden. Sign in to see this information

Instructions for use

Follow the national or WHO protocol.

81 mg/ml pentavalent antimony is equivalent to 0.3 g/ml meglumine antimoniate.

The 5 ml ampoule contains 1.5 g of meglumine antimoniate.

Must be given as IM injection.

Precautions for Use

Contreindicated in patients with renal, cardiac or hepatic impairment.


  • Below 25ºC
  • After opening, use the product immediately.